Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23741,972,1.19 [1.07-1.31],0.0007977672405776
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,23678,192,1.75 [1.40-2.18],6.862916844573165e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,25637,185,1.05 [0.84-1.31],0.6525951023199824
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18140,757,1.44 [1.28-1.63],1.2708380210968744e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25574,122,1.02 [0.78-1.35],0.8649180449623208
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24537,83,1.53 [1.09-2.15],0.0131797622374541
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27000,121,1.02 [0.77-1.33],0.9120006632119992
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,26993,81,0.91 [0.66-1.26],0.5871991342318506
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,23917,65,1.24 [0.85-1.82],0.2702311525352623
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26334,121,1.54 [1.17-2.03],0.0020692041150968
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26283,70,1.36 [0.94-1.96],0.1018737998859222
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27080,76,0.89 [0.63-1.24],0.4827694273047489
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27047,101,1.05 [0.78-1.41],0.770051110051241
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27042,96,1.02 [0.75-1.39],0.8850798550342015
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,26702,64,1.03 [0.71-1.49],0.8878278026637356
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",25900,430,1.27 [1.09-1.47],0.0018595734689303
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25600,130,1.36 [1.04-1.77],0.0258227373370083
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,25766,296,1.23 [1.03-1.47],0.022764686005874
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22178,50,1.06 [0.69-1.63],0.7976128387134457
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22191,63,nan [nan-nan],
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22381,253,nan [nan-nan],
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22389,261,nan [nan-nan],
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22791,663,1.03 [0.91-1.16],0.6144548130027692
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22178,50,0.92 [0.60-1.39],0.6811336467691156
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24293,1009,1.32 [1.20-1.46],2.9097837119016852e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26020,285,1.16 [0.97-1.39],0.1108509236826081
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,26749,101,1.45 [1.07-1.95],0.0153210322907201
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27172,89,1.05 [0.77-1.45],0.7468924666900961
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,26955,58,1.38 [0.93-2.06],0.1095348199652734
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27173,68,1.00 [0.70-1.44],0.9960661849770122
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Stomach,27218,54,0.94 [0.63-1.41],0.7833322151528441
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,26995,267,0.93 [0.77-1.11],0.4068819456743924
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27166,104,0.95 [0.71-1.27],0.7321368682852392
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27165,103,1.00 [0.74-1.34],0.9871968789509128
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27101,69,1.36 [0.94-1.97],0.0979134855220723
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",27103,68,1.33 [0.92-1.92],0.1350087604382105
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,27009,264,1.06 [0.88-1.28],0.5367575319023463
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27177,120,1.10 [0.83-1.45],0.5106244643801698
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,27067,229,0.91 [0.75-1.11],0.3525252817837414
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of breast,27156,136,0.86 [0.67-1.10],0.2170667588329318
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Leiomyoma of uterus,26655,989,0.98 [0.89-1.07],0.616916432387689
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,25834,264,1.44 [1.19-1.73],0.0001428470603106
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,25571,442,1.27 [1.10-1.48],0.0011766260434377
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,25571,442,1.27 [1.10-1.48],0.0011766260434377
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24037,412,1.29 [1.11-1.51],0.0010912068949647
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26650,98,1.01 [0.74-1.36],0.9650989310929596
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,26870,104,0.97 [0.72-1.29],0.8153778900481121
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22568,894,1.10 [0.99-1.22],0.0776454137942531
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24924,893,1.29 [1.17-1.43],1.2361031094057718e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25401,119,2.09 [1.60-2.74],6.825857474756124e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26221,58,1.73 [1.20-2.50],0.0032254569227937
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25388,106,2.09 [1.58-2.77],3.020987760834656e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,25692,410,1.66 [1.42-1.94],1.6087489298875172e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,25683,401,1.63 [1.39-1.90],1.1894789321119543e-09
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25166,190,1.45 [1.15-1.83],0.0018935554092251
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25169,187,1.44 [1.14-1.82],0.0022683661655983
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22377,703,1.09 [0.97-1.22],0.1652713743634665
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21756,82,1.08 [0.77-1.50],0.658625594527666
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22324,650,1.08 [0.96-1.22],0.2179053102616579
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21723,49,0.99 [0.65-1.52],0.9806470738039252
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21742,68,1.12 [0.78-1.62],0.532305455851175
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,22964,620,1.04 [0.92-1.18],0.5284290783700273
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22462,118,1.20 [0.91-1.60],0.203568098901394
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",26984,78,1.07 [0.76-1.50],0.7067807687628466
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27024,46,1.44 [0.91-2.26],0.118588879597894
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25798,39,1.06 [0.65-1.71],0.8245043488115447
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27170,39,1.03 [0.64-1.67],0.8985416673756759
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22383,39,1.07 [0.66-1.72],0.7950263582032402
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Alcohol dependence,25782,23,1.77 [0.95-3.33],0.0737166404027391
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,25674,36,1.69 [1.04-2.75],0.0355812880498489
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22386,42,0.85 [0.56-1.31],0.4740349617889866
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22728,384,1.02 [0.87-1.19],0.8000473478732264
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Depression,25249,341,1.00 [0.85-1.17],0.9859231347583498
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Depression or dysthymia,22509,301,1.04 [0.87-1.24],0.6586487587196703
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22490,146,0.99 [0.78-1.27],0.964167367761232
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Other anxiety disorders,25317,75,0.97 [0.69-1.36],0.851668228004627
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,23462,1621,1.10 [1.01-1.19],0.0202323335069494
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21458,182,0.89 [0.72-1.11],0.2960092798252034
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27019,150,0.86 [0.68-1.09],0.2106663850849806
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,25903,421,1.24 [1.07-1.44],0.003824020449031
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,25617,135,1.13 [0.88-1.47],0.3398723749569217
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,25610,128,1.17 [0.90-1.54],0.2430778469712642
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",26785,118,1.20 [0.91-1.59],0.2005035343806337
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26523,58,1.20 [0.81-1.79],0.3621448937467678
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,25579,97,1.43 [1.06-1.92],0.018464890565854
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,26806,69,1.81 [1.31-2.51],0.0003371644002784
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",25858,854,1.13 [1.02-1.25],0.0228229845055249
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25124,120,1.24 [0.94-1.64],0.1265952886115626
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25551,547,1.10 [0.97-1.25],0.1507409103965512
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,26957,74,1.12 [0.79-1.60],0.5126250541031555
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,26938,55,1.22 [0.81-1.83],0.3444494164130375
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,26736,121,0.80 [0.62-1.03],0.0848712429574637
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26481,420,1.02 [0.88-1.18],0.7655894910058983
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26308,247,1.02 [0.85-1.24],0.8051037986807635
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26132,71,1.01 [0.71-1.44],0.96865678126655
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26196,135,0.87 [0.68-1.11],0.263862766885813
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26163,102,0.94 [0.70-1.25],0.6555655923576715
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23139,174,0.89 [0.71-1.11],0.3111844546457795
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23369,404,1.06 [0.91-1.23],0.4807978623344688
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26185,183,1.15 [0.92-1.44],0.2190901293892937
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26952,34,2.35 [1.55-3.57],5.6930868926001775e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1747,34,1.97 [1.26-3.08],0.0029474801631327
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25239,34,2.54 [1.64-3.93],2.888906966773276e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,26517,88,1.34 [0.97-1.85],0.0805445925176974
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26480,51,1.78 [1.18-2.68],0.005780088367057
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26384,94,0.99 [0.72-1.34],0.927057120961837
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26649,103,1.31 [0.97-1.76],0.0774871446120787
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27095,126,1.21 [0.93-1.59],0.1630961027534112
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26431,101,1.13 [0.84-1.53],0.40904436998822
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20045,2753,1.24 [1.16-1.33],8.568345027315956e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,26645,76,1.55 [1.10-2.19],0.0118427880738462
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21050,2028,1.23 [1.14-1.32],1.818440889106867e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,21071,2049,1.23 [1.14-1.33],7.246232012333624e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19070,48,1.97 [1.26-3.07],0.0030095246788103
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",25547,713,1.18 [1.05-1.32],0.0066136599699079
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,25329,495,1.14 [1.00-1.31],0.0548914097269355
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26560,149,1.17 [0.92-1.50],0.199308029872855
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26635,224,1.32 [1.08-1.61],0.0073742420383687
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27150,27,1.50 [0.85-2.66],0.1606786808430967
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",24926,92,1.63 [1.21-2.21],0.0014907764025176
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25290,468,1.23 [1.07-1.42],0.0039133718444551
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26431,95,1.15 [0.84-1.57],0.3810194299216034
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26534,212,1.35 [1.09-1.66],0.0053398379085071
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26432,96,1.41 [1.04-1.93],0.0291972447119469
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26432,96,1.41 [1.04-1.93],0.0291972447119469
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19115,93,1.47 [1.07-2.03],0.0182652523319715
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23665,39,1.26 [0.78-2.04],0.3465213868392665
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,23702,76,1.11 [0.79-1.57],0.5495403736606039
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16366,100,1.10 [0.81-1.49],0.5550843387378341
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16546,280,1.39 [1.15-1.68],0.0005706428202448
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,23675,49,1.02 [0.66-1.56],0.9334502111879064
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,23683,57,1.22 [0.81-1.82],0.3362202713534223
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26383,98,1.71 [1.29-2.27],0.0002137768643868
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26441,126,1.16 [0.89-1.52],0.2831582265020151
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26481,95,1.08 [0.80-1.47],0.6075771241605217
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26548,83,1.05 [0.76-1.46],0.7635435774170778
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26244,68,1.15 [0.79-1.66],0.4576777892863632
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26287,111,1.54 [1.16-2.04],0.0029136801889031
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25619,130,1.47 [1.12-1.92],0.0050031145022039
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25595,106,1.52 [1.13-2.04],0.0058987155129821
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27006,103,1.56 [1.16-2.09],0.002942568145732
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,26089,600,1.06 [0.94-1.20],0.3596207167382296
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,26088,93,1.34 [0.98-1.85],0.0698241052102261
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22106,2074,1.16 [1.08-1.24],6.972752046813718e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27003,129,1.13 [0.87-1.48],0.3536035167536497
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,25599,199,1.27 [1.02-1.58],0.0304209466017001
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",25579,179,1.22 [0.97-1.54],0.090007863140412
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26316,224,1.03 [0.85-1.26],0.7401347512272254
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26309,217,1.02 [0.83-1.25],0.8721780674723647
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26443,557,1.13 [1.00-1.29],0.0568202794576228
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,25997,111,1.43 [1.08-1.91],0.0137265998994347
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,25967,81,1.08 [0.77-1.51],0.6482135529019823
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26241,355,1.07 [0.91-1.26],0.382232074576542
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,26024,138,1.17 [0.90-1.51],0.2379652844940863
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13116,65,1.11 [0.76-1.63],0.5885771048995465
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24298,1143,1.04 [0.95-1.14],0.4395612562911298
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,26164,156,1.26 [0.99-1.61],0.055561071666703
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26184,176,1.25 [1.00-1.57],0.0533634933103501
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26184,176,1.25 [1.00-1.57],0.0533634933103501
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25193,986,1.00 [0.91-1.10],0.9516826366663168
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Asthma,20203,986,1.04 [0.94-1.15],0.4202337421609901
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20018,986,1.04 [0.95-1.15],0.3886777624595832
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20188,971,1.04 [0.94-1.15],0.4651298766692581
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,26891,82,1.41 [1.01-1.97],0.0423691082354562
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,25444,61,1.64 [1.13-2.39],0.0096661850815191
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",26967,61,1.61 [1.10-2.35],0.0136795499620905
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25437,54,1.85 [1.26-2.71],0.001803322364108
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,25394,88,1.28 [0.93-1.77],0.1317441967648042
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,25498,192,1.40 [1.13-1.75],0.0024102400080413
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26055,92,1.64 [1.21-2.22],0.001376726162437
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18838,5919,1.14 [1.08-1.19],2.973075132558884e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26649,469,1.12 [0.97-1.29],0.1175589668223575
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27172,105,1.05 [0.78-1.41],0.7361463032956976
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,27177,94,1.07 [0.78-1.46],0.6937389625424492
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,26282,102,1.21 [0.90-1.63],0.2100128203965102
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26299,119,1.27 [0.96-1.68],0.0957819485615312
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27163,116,0.95 [0.72-1.25],0.7162994821631521
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26294,114,1.20 [0.90-1.60],0.2032758967099907
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,25992,76,1.23 [0.87-1.74],0.2480154566043128
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27078,47,1.16 [0.75-1.80],0.5038038427532134
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20568,211,1.09 [0.89-1.34],0.3942427632660824
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22635,2278,1.07 [1.00-1.15],0.0453311984843668
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,20641,284,1.05 [0.88-1.26],0.562944391791555
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21080,723,1.04 [0.93-1.16],0.5322652017408447
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20433,76,0.93 [0.67-1.30],0.6867748425235636
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20490,133,1.07 [0.82-1.39],0.6163359748396627
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20397,40,1.42 [0.88-2.30],0.1493375489498763
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,20496,139,1.07 [0.83-1.37],0.620558734715295
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,20430,73,1.21 [0.85-1.72],0.2963041490839032
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27127,52,1.26 [0.83-1.91],0.2836121523422183
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,20488,131,1.11 [0.85-1.44],0.4460787827966364
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21190,833,1.12 [1.01-1.25],0.0319588887736516
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,27052,145,0.97 [0.76-1.24],0.7939701343378032
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,20931,574,1.08 [0.95-1.23],0.2515315324194622
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20533,176,0.87 [0.70-1.08],0.2019870679167897
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27088,140,1.08 [0.84-1.40],0.5367651258278174
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,27023,116,0.97 [0.74-1.28],0.8459632207312463
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,24355,1183,1.09 [0.99-1.19],0.0644864242750473
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,23239,67,0.93 [0.65-1.34],0.6942295805225878
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,23242,70,1.13 [0.79-1.62],0.4935607483436834
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,23280,108,1.17 [0.88-1.57],0.2842968135995936
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24117,945,1.06 [0.96-1.17],0.2668817651953821
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26145,900,1.22 [1.10-1.35],0.0002212371193566
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,21567,2165,1.15 [1.08-1.24],5.910981158108618e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26865,62,2.16 [1.53-3.06],1.226614214076e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27141,90,1.98 [1.47-2.68],7.758896444874835e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,25335,90,2.03 [1.49-2.76],7.028779884612387e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25310,65,2.26 [1.59-3.21],5.515791577634562e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27069,133,1.15 [0.88-1.49],0.3057470878688437
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,25378,133,1.16 [0.89-1.52],0.2618039851730229
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25364,119,1.20 [0.90-1.59],0.206885905915237
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26006,761,1.20 [1.07-1.34],0.0014915680857087
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,25995,750,1.21 [1.08-1.35],0.0010638379039308
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19505,103,1.16 [0.86-1.57],0.3306271850297066
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal stricture,26742,103,1.13 [0.84-1.53],0.4230964210863194
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19466,64,1.28 [0.88-1.88],0.199394195705029
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20065,663,1.15 [1.01-1.29],0.029060067724028
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19639,237,0.97 [0.80-1.17],0.7280450525823882
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19790,388,1.25 [1.07-1.46],0.0049240724341338
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,25522,346,1.20 [1.02-1.41],0.0321269904563184
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,26701,125,1.20 [0.91-1.57],0.1957481664034657
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19524,122,1.03 [0.79-1.36],0.8188301565765164
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19449,47,1.67 [1.09-2.56],0.0194886606480444
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20285,883,1.12 [1.01-1.25],0.0296151331574219
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,19638,236,1.44 [1.18-1.76],0.0003125316095762
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26683,107,1.17 [0.87-1.56],0.2980815773077826
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,26431,100,2.22 [1.71-2.87],1.5654732833475531e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,26381,50,1.72 [1.17-2.53],0.0057075059011798
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",25662,867,1.09 [0.98-1.21],0.1083405114127709
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,25520,725,1.08 [0.97-1.21],0.1599791921001958
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,24926,131,1.09 [0.84-1.41],0.5339276300165374
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24865,70,1.27 [0.88-1.82],0.2046750316458997
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,24855,60,1.42 [0.97-2.10],0.0739354532382016
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27056,60,1.39 [0.95-2.03],0.0928440737709404
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,25820,297,1.28 [1.07-1.53],0.0072070639445885
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25623,100,1.29 [0.95-1.75],0.1065895599927079
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,25608,85,nan [nan-nan],
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25562,39,1.31 [0.80-2.12],0.2798463992766457
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,25686,163,1.21 [0.95-1.54],0.1140199141300452
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,25676,153,1.28 [1.00-1.63],0.0527100752636969
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24087,1604,1.09 [1.01-1.18],0.0366012036751186
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,26750,111,0.93 [0.70-1.22],0.5912809941797854
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26761,449,1.02 [0.89-1.18],0.7624690751867734
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,25640,692,1.08 [0.96-1.21],0.1894147143024878
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26407,325,1.05 [0.89-1.24],0.5563375364943355
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26154,72,1.17 [0.82-1.68],0.3859754973772716
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26288,206,1.05 [0.85-1.30],0.6340477132837148
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,26926,89,1.69 [1.25-2.30],0.0006672558296396
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26901,64,1.96 [1.40-2.75],9.91514602904206e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26887,50,1.84 [1.24-2.72],0.0024578757309365
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,26944,55,0.79 [0.54-1.16],0.2297185967293832
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,26941,52,0.84 [0.56-1.25],0.3810088202319701
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26371,59,0.76 [0.53-1.08],0.1297114105495914
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26661,349,1.04 [0.88-1.22],0.637808309114369
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25050,102,1.03 [0.76-1.38],0.8637300279367766
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25100,152,1.24 [0.97-1.59],0.0907808347561
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25057,109,1.18 [0.88-1.58],0.2635064290881383
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25202,254,1.06 [0.88-1.28],0.553210588673458
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25178,230,1.11 [0.91-1.36],0.3091251653314678
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19192,4367,1.11 [1.05-1.17],0.0002027837889142
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20903,2514,1.11 [1.04-1.19],0.0013935325764113
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24430,1327,1.03 [0.95-1.12],0.4772345562476139
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18600,211,1.52 [1.23-1.88],8.987517103689472e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18902,513,1.30 [1.13-1.50],0.0002091047658358
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26637,202,1.48 [1.19-1.82],0.0003169108126584
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26653,184,1.55 [1.24-1.93],0.0001025392077489
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19606,1217,1.07 [0.98-1.18],0.1346257284829731
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22284,1217,1.05 [0.96-1.15],0.268126674912265
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18401,12,0.94 [0.38-2.31],0.8945047628124952
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27009,12,0.92 [0.39-2.16],0.84888008119188
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18663,274,1.17 [0.96-1.41],0.1148894660898263
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18476,87,0.77 [0.59-1.02],0.0669664492230377
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18691,302,1.13 [0.94-1.35],0.1900159285796159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27016,154,1.00 [0.79-1.27],0.9875240682318532
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18871,482,1.02 [0.88-1.18],0.7935888039237973
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18870,481,1.12 [0.97-1.30],0.1098892438798535
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19800,1411,1.09 [1.00-1.19],0.0421080674080763
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18495,106,0.83 [0.63-1.11],0.2075668437675131
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18811,422,1.13 [0.97-1.31],0.113732268468774
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18472,83,1.05 [0.75-1.47],0.7646017272652152
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18492,103,0.92 [0.69-1.24],0.5866745698652243
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18760,371,0.90 [0.77-1.06],0.2057176294367958
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18703,314,0.87 [0.74-1.03],0.104996100938834
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20271,299,1.35 [1.13-1.62],0.0009436127902273
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26407,217,1.67 [1.36-2.04],6.388980579881312e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26282,92,1.67 [1.23-2.26],0.0009663830621613
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23281,80,1.08 [0.77-1.51],0.6624561330463945
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23503,302,1.14 [0.96-1.36],0.1412029452166305
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24215,1014,1.05 [0.96-1.16],0.2838236901961669
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23411,210,1.11 [0.90-1.36],0.3423496270791039
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23278,77,1.14 [0.81-1.60],0.4623471372218208
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24008,807,1.03 [0.93-1.15],0.5590401916807921
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23252,51,0.79 [0.53-1.16],0.2300953388289772
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23442,241,1.06 [0.87-1.29],0.5424353837979958
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23302,101,1.16 [0.86-1.57],0.3363228712435349
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23292,91,1.03 [0.75-1.41],0.8469897490349974
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23360,159,1.11 [0.87-1.41],0.394149857399073
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23275,74,1.13 [0.80-1.61],0.4827112474478715
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23555,354,1.02 [0.87-1.19],0.834904754350294
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23484,381,1.09 [0.93-1.27],0.3004146430095081
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23173,70,1.32 [0.91-1.90],0.1382225710502614
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23211,108,1.31 [0.98-1.76],0.0711363621585652
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23246,143,0.89 [0.70-1.13],0.3482066734900048
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23142,39,0.95 [0.59-1.52],0.8225610580820137
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23160,57,1.04 [0.70-1.55],0.8415518769424625
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23144,41,0.88 [0.56-1.38],0.5698133500409555
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23377,274,1.03 [0.86-1.23],0.7714310412904896
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23162,59,0.99 [0.68-1.46],0.9736572642191832
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23171,68,1.03 [0.72-1.48],0.8614254093709404
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23239,136,1.07 [0.83-1.39],0.5902430251358017
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23183,80,1.10 [0.79-1.55],0.5670020834904984
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",23642,539,1.03 [0.90-1.17],0.7030858775916118
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23293,190,1.23 [0.99-1.54],0.0655669876791134
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23390,287,0.93 [0.78-1.10],0.3850251957097373
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24506,238,1.02 [0.83-1.24],0.8737186506411944
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24753,485,0.99 [0.87-1.14],0.9290490945346996
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24308,40,1.10 [0.68-1.78],0.6954274536361446
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24334,66,0.86 [0.60-1.24],0.4226855644611832
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24384,116,1.03 [0.78-1.37],0.8142876335259568
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22210,6041,1.04 [1.00-1.09],0.070649880780132
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24776,201,1.42 [1.14-1.76],0.0018859553009143
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24620,45,1.09 [0.69-1.72],0.7175807687967656
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24945,36,1.25 [0.75-2.08],0.3910992467354689
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,24957,48,1.61 [1.04-2.50],0.0333334247481087
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24949,40,1.84 [1.15-2.95],0.0111250435255265
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,26971,128,1.04 [0.80-1.36],0.7588876410892855
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,26846,64,1.07 [0.73-1.55],0.7333737926004928
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26941,98,1.13 [0.83-1.53],0.4450689716383916
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26877,34,0.63 [0.42-0.95],0.0283576911939298
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25018,1248,1.07 [0.98-1.17],0.1144457573253684
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,23908,138,1.06 [0.82-1.37],0.6464217530686818
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23857,87,1.12 [0.81-1.55],0.5016251948689269
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,23937,167,1.09 [0.87-1.38],0.4526121024839518
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23857,87,1.04 [0.76-1.43],0.8074788162784746
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,24751,981,1.10 [0.99-1.21],0.0692241538953403
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26896,474,0.95 [0.83-1.09],0.4929361735744818
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26570,148,1.04 [0.81-1.33],0.7478916483325878
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26590,168,1.01 [0.80-1.27],0.9626398892182038
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26533,111,0.98 [0.74-1.30],0.9072212599315324
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26843,543,1.02 [0.89-1.16],0.7959233813070734
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26432,132,1.03 [0.79-1.34],0.8288425872782258
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26539,239,1.01 [0.83-1.22],0.9548732282005844
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24803,4518,0.98 [0.94-1.03],0.5357853596847447
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Endometriosis,20642,357,1.11 [0.95-1.31],0.202136735488928
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20381,96,0.96 [0.71-1.31],0.8107044869202271
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20449,164,1.14 [0.90-1.45],0.269713307396482
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21061,776,0.98 [0.88-1.10],0.7711591732995426
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20687,402,1.06 [0.91-1.23],0.4441828066184313
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21226,941,0.95 [0.86-1.05],0.3310529300813852
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20598,313,0.93 [0.79-1.10],0.3761435851831588
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20715,430,1.17 [1.01-1.35],0.0418616198892926
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20381,96,1.25 [0.91-1.71],0.1618636329650293
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20468,183,1.05 [0.84-1.31],0.6633601571530414
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27171,260,1.07 [0.89-1.30],0.4642927540389443
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27182,246,1.09 [0.89-1.32],0.4094817906936771
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27208,136,1.00 [0.77-1.29],0.9926108154202616
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27198,150,1.00 [0.78-1.27],0.9688805044909884
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20429,144,1.08 [0.84-1.39],0.526525026053063
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20399,114,0.79 [0.61-1.03],0.0792723090643086
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20424,139,0.88 [0.69-1.12],0.3020237776937445
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Irregular menses,27100,458,1.09 [0.94-1.26],0.2414987432751048
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21602,1317,1.04 [0.95-1.13],0.3712686287280043
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21147,862,1.04 [0.93-1.15],0.5027732955767287
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27187,191,1.07 [0.86-1.33],0.5731568284457096
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20746,461,0.87 [0.76-1.00],0.0477014328145026
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20606,321,1.17 [0.98-1.39],0.0767492312725512
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21173,888,1.01 [0.91-1.12],0.8532425594201323
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female infertility,20396,111,0.95 [0.72-1.27],0.7367024330717967
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20389,104,1.00 [0.74-1.35],0.9945938709945716
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27208,867,1.11 [0.99-1.24],0.0878217287399652
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27210,1182,1.10 [1.00-1.22],0.0594361312786647
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27207,474,1.03 [0.89-1.19],0.7153012380127186
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26868,135,1.02 [0.78-1.33],0.8831563371165279
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26922,189,1.19 [0.95-1.50],0.1343587188618374
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26898,165,0.84 [0.67-1.05],0.1284421977637825
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27225,168,0.80 [0.64-1.01],0.0624611842698821
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27227,165,0.79 [0.63-0.99],0.0427367454736306
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27222,410,1.17 [1.00-1.37],0.0550262859023162
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26937,125,1.06 [0.80-1.40],0.7004723406255315
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27037,225,1.25 [1.01-1.54],0.0420306657013333
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26490,149,0.96 [0.75-1.23],0.7467183834321125
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26539,198,0.94 [0.75-1.17],0.5691869903435117
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26592,251,1.10 [0.90-1.34],0.3655428558936143
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26486,145,1.70 [1.30-2.23],9.134276981601e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26478,137,1.05 [0.81-1.37],0.7140859881454991
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26487,146,0.96 [0.75-1.24],0.7681362683198134
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26257,229,0.93 [0.75-1.14],0.4674759983497936
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26461,433,1.05 [0.90-1.23],0.5195140419911743
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26689,661,1.15 [1.00-1.31],0.042183350109727
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27226,168,1.04 [0.82-1.32],0.7583659924683438
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25793,127,1.06 [0.80-1.40],0.7002934528800582
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26130,102,1.32 [0.96-1.82],0.0844316806110409
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27234,333,1.07 [0.90-1.27],0.4606079667213976
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27155,254,1.07 [0.88-1.31],0.4784445329012143
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27222,250,0.86 [0.71-1.04],0.1183898363603766
SLAMF1,Signaling lymphocytic activation molecule,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27213,241,0.86 [0.71-1.04],0.1251536772744119
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",26932,42,1.61 [1.04-2.49],0.0311409857204487
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24358,636,1.07 [0.94-1.20],0.3031875603232878
